ASTROTECH Corp current report, Q2 FY2022

Astrotech Corp (ASTC) 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Astrotech Corporation on June 23, 2022. The report addresses a corporate event occurring on the same date involving the company's subsidiary, BreathTech Corporation.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual amendment rather than financial performance data.

Material Changes

On June 23, 2022, Astrotech Corporation announced an amendment to the Joint Development and Option Agreement between its subsidiary, BreathTech Corporation, and the Cleveland Clinic Foundation. The amendment includes additional areas of focus for the collaboration.

Guidance, Outlook, and Risks

The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the context of the agreement amendment. The primary disclosure is the expansion of the partnership scope with the Cleveland Clinic Foundation.

Investor Verification Checklist

  • Review the attached press release (Exhibit 99.1) for specific details on the "additional areas of focus" added to the agreement.
  • Verify the strategic implications of the expanded partnership between BreathTech Corporation and the Cleveland Clinic Foundation.
  • Check subsequent filings for any financial impact or milestones resulting from this amendment.